Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Geroscience ; 45(3): 1557-1571, 2023 06.
Article in English | MEDLINE | ID: mdl-36725819

ABSTRACT

Extracellular vesicles (EVs) are mediators of cellular communication that can be released by almost all cell types in both physiological and pathological conditions and are present in most biological fluids. Such characteristics make them attractive in the research of biomarkers for age-related pathological conditions. Based on this, the aim of the present study was to examine the changes in EV concentration and size in the context of frailty, a geriatric syndrome associated with a progressive physical and cognitive decline. Specifically, total EVs and neural and microglial-derived EVs (NDVs and MDVs respectively) were investigated in plasma of frail and non-frail controls (CTRL), mild cognitive impairment (MCI) subjects, and in Alzheimer's disease (AD) patients. Results provided evidence that AD patients displayed diminished NDV concentration (3.61 × 109 ± 1.92 × 109 vs 7.16 × 109 ± 4.3 × 109 particles/ml) and showed high diagnostic performance. They are able to discriminate between AD and CTRL with an area under the curve of 0.80, a sensitivity of 78.95% and a specificity of 85.7%, considering the cut-off of 5.27 × 109 particles/ml. Importantly, we also found that MDV concentration was increased in frail MCI patients compared to CTRL (5.89 × 109 ± 3.98 × 109 vs 3.16 × 109 ± 3.04 × 109 particles/ml, P < 0.05) and showed high neurotoxic effect on neurons. MDV concentration discriminate frail MCI vs non-frail CTRL (AUC = 0.76) with a sensitivity of 80% and a specificity of 70%, considering the cut-off of 2.69 × 109 particles/ml. Altogether, these results demonstrated an alteration in NDV and MDV release during cognitive decline, providing important insight into the role of EVs in frailty status.


Subject(s)
Alzheimer Disease , Cognitive Dysfunction , Extracellular Vesicles , Frailty , Humans , Aged , Microglia , Cognitive Dysfunction/metabolism , Alzheimer Disease/diagnosis , Extracellular Vesicles/metabolism
2.
J Cell Biol ; 126(6): 1527-36, 1994 Sep.
Article in English | MEDLINE | ID: mdl-8089183

ABSTRACT

Calcium imaging techniques were used to obtain a clear although indirect evidence about the distribution of functional glutamate receptors of NMDA and non-NMDA type in cultured hippocampal neurons during establishment of polarity and synaptogenesis. Glutamate receptors were expressed and were already functional as early as one day after plating. At this stage NMDA and non-NMDA receptors were distributed in all plasmalemmal areas. During the establishment of neuronal polarity, responses to either types of glutamate receptors became restricted to the soma and dendrites. Compartmentalization of glutamate receptors occurred at stages of development when synaptic vesicles were already fully segregated to the axon. Formation of synapses was accompanied by a further redistribution of receptors, which segregated to synapse-enriched portions of dendrites. Receptor compartmentalization and dendritic redistribution as well as accumulation of synaptic vesicles at synaptic sites occurred also in neurons cultured in the presence of either the sodium channel blocker tetrodotoxin or glutamate receptor antagonists. These results indicate that signals generated by neuronal electrical activity or receptor activation are not involved in the establishment of neuronal polarity and synaptogenesis.


Subject(s)
Calcium/physiology , Cell Polarity/physiology , Neurons/cytology , Receptors, Glutamate/metabolism , Signal Transduction/physiology , Synapses/physiology , Animals , Calcium/metabolism , Cells, Cultured , Excitatory Amino Acid Antagonists , Hippocampus/cytology , Hippocampus/embryology , N-Methylaspartate/pharmacology , Neurons/drug effects , Neurons/metabolism , Neurons/ultrastructure , Potassium Chloride/pharmacology , Rats , Receptors, Glutamate/drug effects , Receptors, N-Methyl-D-Aspartate/metabolism , Tetrodotoxin/pharmacology
3.
J Neurosci ; 19(16): 6723-32, 1999 Aug 15.
Article in English | MEDLINE | ID: mdl-10436029

ABSTRACT

Recycling synaptic vesicles are already present in isolated axons of developing neurons (Matteoli et al., Zakharenko et al., 1999). This vesicle recycling is distinct from the vesicular traffic implicated in axon outgrowth. Formation of synaptic contacts coincides with a clustering of synaptic vesicles at the contact site and with a downregulation of their basal rate of exo-endocytosis (Kraszewski et al, 1995; Coco et al., 1998) We report here that tetanus toxin-mediated cleavage of synaptobrevin/vesicle-associated membrane protein (VAMP2), previously shown not to affect axon outgrowth, also does not inhibit synaptic vesicle exocytosis in isolated axons, despite its potent blocking effect on their exocytosis at synapses. This differential effect of tetanus toxin could be seen even on different branches of a same neuron. In contrast, botulinum toxins A and E [which cleave synaptosome-associated protein of 25 kDa. (SNAP-25)] and F (which cleaves synaptobrevin/VAMP1 and 2) blocked synaptic vesicle exocytosis both in isolated axons and at synapses, strongly suggesting that this process is dependent on "classical" synaptic SNAP receptor (SNARE) complexes both before and after synaptogenesis. A tetanus toxin-resistant form of synaptic vesicle recycling, which proceeds in the absence of external stimuli and is sensitive to botulinum toxin F, E, and A, persists at mature synapses. These data suggest the involvement of a tetanus toxin-resistant, but botulinum F-sensitive, isoform of synaptobrevin/VAMP in synaptic vesicle exocytosis before synapse formation and the partial persistence of this form of exocytosis at mature synaptic contacts.


Subject(s)
Axons/drug effects , Exocytosis/drug effects , Synapses/drug effects , Synaptic Vesicles/drug effects , Tetanus Toxin/pharmacology , Vesicular Transport Proteins , Animals , Axons/ultrastructure , Cells, Cultured , Cellular Senescence , Hippocampus/drug effects , Hippocampus/ultrastructure , Membrane Proteins/drug effects , Nerve Tissue Proteins/drug effects , Neurons/drug effects , Neurons/ultrastructure , Rats , SNARE Proteins , Synapses/ultrastructure
4.
J Neurosci ; 21(17): 6588-96, 2001 Sep 01.
Article in English | MEDLINE | ID: mdl-11517248

ABSTRACT

During development of neuronal circuits, presynaptic and postsynaptic functions are adjusted in concert, to optimize interneuronal signaling. We have investigated whether activation of glutamate receptors affects presynaptic function during synapse formation, when constitutive synaptic vesicle recycling is downregulated. Using primary cultures of hippocampal neurons as a model system, we have found that chronic exposure to both NMDA and non-NMDA glutamate receptor blockers during synaptogenesis produces an increase in miniature EPSC (mEPSC) frequency, with no significant changes in mEPSC amplitude or in the number of synapses. Enhanced synaptic vesicle recycling, selectively in glutamatergic nerve terminals, was confirmed by the increased uptake of antibodies directed against the lumenal domain of synaptotagmin. No increased uptake was detected in neuronal cultures grown in the chronic presence of TTX, speaking against an indirect effect caused by decreased electrical activity. Enhanced mEPSC frequency correlated with a reduction of synaptophysin-synaptobrevin-vesicle-associated membrane protein 2 (VAMP2) complexes detectable by immunoprecipitation. Intracellular perfusion with a peptide that inhibits the binding of synaptophysin to synaptobrevin-VAMP2 induced a remarkable increase of mEPSC frequency in control but not in glutamate receptor blocker-treated neurons. These findings suggest that activation of glutamate receptors plays a role in the downregulation of the basal rate of synaptic vesicle recycling that accompanies synapse formation. They also suggest that one of the mechanisms through which this downregulation is achieved is an increased interaction of synaptophysin with synaptobrevin-VAMP2.


Subject(s)
Membrane Proteins/metabolism , Presynaptic Terminals/metabolism , Receptors, Glutamate/metabolism , Synaptophysin/metabolism , Animals , Cells, Cultured , Down-Regulation/drug effects , Endocytosis/drug effects , Endocytosis/physiology , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Exocytosis/drug effects , Exocytosis/physiology , Hippocampus , Macromolecular Substances , Neurons/cytology , Neurons/drug effects , Neurons/metabolism , Patch-Clamp Techniques , Protein Binding/drug effects , R-SNARE Proteins , Rats , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Synaptic Transmission/drug effects , Synaptic Vesicles/metabolism , Tetrodotoxin/pharmacology
5.
Neuroscience ; 131(4): 813-23, 2005.
Article in English | MEDLINE | ID: mdl-15749336

ABSTRACT

Synaptosomal associated protein of 25 kDa (SNAP-25) is a component of the soluble N-ethylmaleimide-sensitive fusion protein (NSF) attachment protein receptor (SNARE) complex which plays a central role in synaptic vesicle exocytosis. We have previously demonstrated that adult rat hippocampal GABAergic synapses, both in culture and in brain, are virtually devoid of SNAP-25 immunoreactivity and are less sensitive to the action of botulinum toxin type A, which cleaves this SNARE protein [Neuron 41 (2004) 599]. In the present study, we extend our findings to the adult mouse hippocampus and we also provide demonstration that hippocampal inhibitory synapses lacking SNAP-25 labeling belong to parvalbumin-, calretinin- and cholecystokinin-positive interneurons. A partial colocalization between SNAP-25 and glutamic acid decarboxylase is instead detectable in developing mouse hippocampus at P0 and, at a lesser extent, at P5. In rat embryonic hippocampal cultures at early developmental stages, SNAP-25 immunoreactivity is detectable in a percentage of GABAergic neurons, which progressively reduces with time in culture. Consistent with the presence of the substrate, botulinum toxin type A is partially effective in inhibiting synaptic vesicle recycling in immature GABAergic neurons. Since SNAP-25, beside its role as a SNARE protein, is involved in additional processes, such as neurite outgrowth and regulation of calcium dynamics, the presence of higher levels of the protein at specific stages of neuronal differentiation may have implications for the construction and for the functional properties of brain circuits.


Subject(s)
Hippocampus/metabolism , Membrane Proteins/metabolism , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Animals , Biomarkers , Botulinum Toxins, Type A/pharmacology , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cells, Cultured , Fluorescent Antibody Technique, Indirect , Hippocampus/cytology , Immunohistochemistry , Interneurons/metabolism , Male , Membrane Proteins/immunology , Mice , Nerve Tissue Proteins/immunology , Neuromuscular Agents/pharmacology , RNA, Messenger/biosynthesis , RNA, Messenger/isolation & purification , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Synapses/drug effects , Synapses/physiology , Synaptic Vesicles/drug effects , Synaptosomal-Associated Protein 25 , gamma-Aminobutyric Acid/physiology
6.
Eur J Cell Biol ; 66(3): 246-56, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7774610

ABSTRACT

Exocytosis of synaptic vesicles (SV) results in the surface exposure of lumenal epitopes of SV proteins. We have recently described the use of antibodies directed against the lumenal N-terminus of synaptotagmin I (Sytlum-Abs) to morphologically monitor exo-endocytic recycling of SVs. We report here that a radioimmunoassay based on these antibodies can be used to quantify levels of synaptic activity in primary neuronal cultures. High density cultures of hippocampal neurons grown in the absence of glia were used for these studies. A significant cell surface pool of synaptotagmin I immunoreactivity was detectable by Sytlum-Abs at steady state. The increase in the amount of Sytlum-Abs which became cell bound during a 3 min incubation at 37 degrees C over the Ab bound to this cell surface pool, was substantially higher in depolarizing media containing extracellular Ca2+ than in Ca(2+)-free media. Incubation of the cultures with Sytlum-Abs for longer time periods indicated a sustained increase in the rate of SV exocytosis in depolarizing media which lasted for at least 1 h. This increase was completely abolished by pretreating the neurons with tetanus toxin and this block correlated with a disappearance of synaptobrevin immunoreactivity. This radioimmunoassay therefore offers a new way to monitor SV exocytosis of neuronal populations in vitro irrespective of the type of neurotransmitter secreted and of postsynaptic effects.


Subject(s)
Calcium-Binding Proteins , Exocytosis , Hippocampus/metabolism , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Radioimmunoassay/methods , Synaptic Vesicles/metabolism , Animals , Biological Transport , Cells, Cultured , Culture Techniques/methods , Fluorescent Antibody Technique , Hippocampus/cytology , Hippocampus/embryology , Membrane Proteins/metabolism , Neurons/drug effects , Neurons/ultrastructure , R-SNARE Proteins , Rats , Synaptic Vesicles/drug effects , Synaptic Vesicles/ultrastructure , Synaptotagmin I , Synaptotagmins , Tetanus Toxin/pharmacology
8.
J Physiol Paris ; 89(1): 51-5, 1995.
Article in English | MEDLINE | ID: mdl-7581299

ABSTRACT

To improve our understanding of the mechanisms which regulate the formation and the functional maturation of synaptic contacts between neurons, we used hippocampal neurons maintained in primary cultures as experimental system. In this model, which offers several advantages for the study of neuronal development and synaptogenesis, we investigated some of the cellular mechanisms underlying the formation of presynaptic and postsynaptic compartments.


Subject(s)
Hippocampus/physiology , Synapses/physiology , Animals , Cells, Cultured , Hippocampus/cytology , Humans
9.
Lab Chip ; 14(15): 2860-6, 2014 Aug 07.
Article in English | MEDLINE | ID: mdl-24914747

ABSTRACT

Open microscale cultures of primary central nervous system (CNS) cells have been implemented in microfluidic chips that can expose the cells to physiological fluidic shear stress conditions. Cells in the chips were exposed to differently aggregated forms of beta-amyloid (Aß), i.e. conditions mimicking an Alzheimer's Disease environment, and treated with CNS drugs in order to assess the contribution of glial cells during pharmacological treatments. FTY720, a drug approved for the treatment of Multiple Sclerosis, was found to play a marked neuroprotective role in neuronal cultures as well as in microglia-enriched neuronal cultures, preventing neurodegeneration after cell exposure to neurotoxic oligomers of Aß.


Subject(s)
Amyloid beta-Peptides/antagonists & inhibitors , High-Throughput Screening Assays/instrumentation , Hippocampus/drug effects , Microfluidic Analytical Techniques/instrumentation , Neurons/drug effects , Neuroprotective Agents/pharmacology , Peptide Fragments/antagonists & inhibitors , Protein Aggregation, Pathological/drug therapy , Alzheimer Disease/drug therapy , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/metabolism , Animals , Cell Survival/drug effects , Cells, Cultured , Dimethylpolysiloxanes/chemistry , Embryo, Mammalian/cytology , Equipment Design , Fingolimod Hydrochloride , Hippocampus/cytology , Hippocampus/metabolism , Hippocampus/ultrastructure , Microglia/cytology , Microglia/drug effects , Microglia/metabolism , Microglia/ultrastructure , Neurons/cytology , Neurons/metabolism , Neurons/ultrastructure , Neuroprotective Agents/therapeutic use , Nootropic Agents/pharmacology , Nootropic Agents/therapeutic use , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Printing, Three-Dimensional , Propylene Glycols/pharmacology , Propylene Glycols/therapeutic use , Protein Aggregation, Pathological/metabolism , Protein Aggregation, Pathological/pathology , Rats , Shear Strength , Sphingosine/analogs & derivatives , Sphingosine/pharmacology , Sphingosine/therapeutic use , Surface Properties
10.
Cell Death Differ ; 21(4): 582-93, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24336048

ABSTRACT

Alzheimer's disease (AD) is characterized by extracellular amyloid-ß (Aß) deposition, which activates microglia, induces neuroinflammation and drives neurodegeneration. Recent evidence indicates that soluble pre-fibrillar Aß species, rather than insoluble fibrils, are the most toxic forms of Aß. Preventing soluble Aß formation represents, therefore, a major goal in AD. We investigated whether microvesicles (MVs) released extracellularly by reactive microglia may contribute to AD degeneration. We found that production of myeloid MVs, likely of microglial origin, is strikingly high in AD patients and in subjects with mild cognitive impairment and that AD MVs are toxic for cultured neurons. The mechanism responsible for MV neurotoxicity was defined in vitro using MVs produced by primary microglia. We demonstrated that neurotoxicity of MVs results from (i) the capability of MV lipids to promote formation of soluble Aß species from extracellular insoluble aggregates and (ii) from the presence of neurotoxic Aß forms trafficked to MVs after Aß internalization into microglia. MV neurotoxicity was neutralized by the Aß-interacting protein PrP and anti-Aß antibodies, which prevented binding to neurons of neurotoxic soluble Aß species. This study identifies microglia-derived MVs as a novel mechanism by which microglia participate in AD degeneration, and suggest new therapeutic strategies for the treatment of the disease.


Subject(s)
Amyloid beta-Peptides/toxicity , Microglia/metabolism , Neurons/drug effects , Peptide Fragments/toxicity , Transport Vesicles/metabolism , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/chemistry , Animals , Cell Survival/drug effects , Cells, Cultured , Excitatory Amino Acid Antagonists/pharmacology , Female , Humans , Interleukin-1beta/metabolism , Male , Microglia/drug effects , Neurons/cytology , Neurons/metabolism , Peptide Fragments/chemistry , PrPC Proteins/metabolism , Rats , Solubility , Transport Vesicles/chemistry , Tumor Necrosis Factor-alpha/metabolism
11.
J Immunol ; 166(10): 6383-91, 2001 May 15.
Article in English | MEDLINE | ID: mdl-11342663

ABSTRACT

Calcium-mediated intercellular communication is a mechanism by which astrocytes communicate with each other and modulate the activity of adjacent cells, including neurons and oligodendrocytes. We have investigated whether microglia, the immune effector cells involved in several diseases of the CNS, are actively involved in this communication network. To address this issue, we analyzed calcium dynamics in fura-2-loaded cocultures of astrocytes and microglia under physiological conditions and in the presence of the inflammatory cytokine IFN-gamma. The intracellular calcium increases in astrocytes, occurring spontaneously or as a result of mechanical or bradykinin stimulation, induced the release of ATP, which, in turn, was responsible for triggering a delayed calcium response in microglial cells. Repeated stimulations of microglial cells by astrocyte-released ATP activated P2X(7) purinergic receptor on microglial cells and greatly increased membrane permeability, eventually leading to microglial apoptosis. IFN-gamma increased ATP release and potentiated the P2X(7)-mediated cytolytic effect. This is the first study showing that ATP mediates a form of calcium signaling between astrocytes and microglia. This mechanism of intercellular communication may be involved in controlling the number and function of microglial cells under pathophysiologic CNS conditions.


Subject(s)
Adenosine Triphosphate/physiology , Astrocytes/immunology , Astrocytes/metabolism , Calcium Signaling/immunology , Interferon-gamma/physiology , Microglia/immunology , Microglia/metabolism , Adenosine Triphosphate/metabolism , Animals , Apoptosis/immunology , Calcium/metabolism , Cations, Divalent/metabolism , Cell Communication/immunology , Cell Death/immunology , Cells, Cultured , Coculture Techniques , Cytotoxicity, Immunologic , Drug Synergism , Intracellular Fluid/metabolism , Microglia/cytology , Rats , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2X7
12.
Proc Natl Acad Sci U S A ; 92(14): 6449-53, 1995 Jul 03.
Article in English | MEDLINE | ID: mdl-7604011

ABSTRACT

Hippocampal neurons maintained in primary culture recycle synaptic vesicles and express functional glutamate receptors since early stages of neuronal development. By analyzing glutamate-induced cytosolic calcium changes to sense presynaptically released neurotransmitter, we demonstrate that the ability of neurons to release glutamate in the extracellular space is temporally coincident with the property of synaptic vesicles to undergo exocytotic-endocytotic recycling. Neuronal differentiation and maturation of synaptic contacts coincide with a change in the subtype of calcium channels primarily involved in controlling neurosecretion. Whereas omega-agatoxin IVA-sensitive channels play a role in controlling neurotransmitter secretion at all stages of neuronal differentiation, omega-conotoxin GVIA-sensitive channels are primarily involved in mediating glutamate release at early developmental stages only.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium Channels/physiology , Calcium/metabolism , Glutamic Acid/metabolism , Hippocampus/physiology , Neurons/physiology , Peptides/pharmacology , Spider Venoms/pharmacology , Synapses/physiology , 2-Amino-5-phosphonovalerate/pharmacology , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Animals , Cadmium/pharmacology , Calcium Channels/drug effects , Cell Differentiation/drug effects , Cells, Cultured , Fetus , Glutamic Acid/pharmacology , Glycine/pharmacology , Kinetics , Magnesium/pharmacology , N-Methylaspartate/pharmacology , Neurons/cytology , Neurons/drug effects , Rats , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/physiology , Synapses/drug effects , Time Factors , omega-Agatoxin IVA , omega-Conotoxin GVIA
13.
Eur J Neurosci ; 11(2): 389-97, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10051739

ABSTRACT

We have detected spontaneous, synchronous calcium oscillations, associated with variations in membrane potential, in hippocampal neurons maintained in primary culture. The oscillatory activity is synaptically driven, as it is blocked by tetrodotoxin, by the glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and by toxins inhibiting neurotransmitter release from presynaptic nerve endings. Neuronal oscillations do not require for their expression the presence of a polyneuronal network and are not primarily influenced by the gamma-aminobutyric acid (GABA(A)) receptor antagonist picrotoxin, suggesting that they entirely rely on glutamatergic neurotransmission. Synaptic and intrinsic conductances shape the synchronized oscillations in hippocampal neurons. The concomitant activation of N-methyl-D-aspartate (NMDA) receptors and voltage-activated L-type calcium channels allows calcium entering from the extracellular medium and sustaining the long depolarization, which shapes every single calcium wave.


Subject(s)
Neurons/cytology , Neurons/physiology , Periodicity , Synapses/physiology , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Action Potentials/drug effects , Action Potentials/physiology , Animals , Calcium/pharmacokinetics , Calcium Channel Blockers/pharmacology , Calcium Channels/physiology , Cells, Cultured , Electric Stimulation , Electrophysiology , Excitatory Amino Acid Antagonists/pharmacology , Fetus/cytology , Fluorescent Dyes , Fura-2 , GABA Antagonists/pharmacology , Hippocampus/cytology , Ion Channel Gating/physiology , Neurons/chemistry , Nimodipine/pharmacology , Picrotoxin/pharmacology , Rats , Receptors, GABA-A/physiology , Receptors, N-Methyl-D-Aspartate/physiology , Spider Venoms/pharmacology , Synapses/chemistry , Synaptic Transmission/physiology , Tetrodotoxin/pharmacology , omega-Agatoxin IVA
14.
Philos Trans R Soc Lond B Biol Sci ; 354(1381): 403-9, 1999 Feb 28.
Article in English | MEDLINE | ID: mdl-10212490

ABSTRACT

Glial cells represent the most abundant cell population in the central nervous system and for years they have been thought to provide just structural and trophic support to neurons. Recently, several studies were performed, leading to the identification of an active interaction between glia and neurons. This paper focuses on the role played by glial cells at the level of the synapse, reviewing recent data defining how glia is determinant in synaptogenesis, in the modulation of fully working synaptic contacts and in synaptic plasticity.


Subject(s)
Neuroglia/physiology , Synapses/physiology , Animals , Astrocytes/physiology , Biological Transport, Active , Calcium Signaling/physiology , Glutamic Acid/physiology , Models, Neurological , Nervous System/growth & development , Neuronal Plasticity/physiology , Neurons/physiology
15.
J Neurochem ; 71(5): 1987-92, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9798923

ABSTRACT

Using an immunocytochemical assay to monitor synaptic vesicle exocytosis/endocytosis independently of neurotransmitter release, we have investigated some aspects of vesicle recycling in hippocampal neurons at different developmental stages. A calcium- and depolarization-dependent exocytotic/endocytotic recycling of synaptic vesicles was found to take place in neurons already before the formation of synaptic contacts. The analysis of synaptic vesicle recycling at different calcium concentrations revealed the presence of two release components: the first one activated by low calcium concentrations and sustaining vesicle recycling before synaptogenesis, and a second one activated by high calcium concentrations, which is specifically turned on after the establishment of synaptic contacts. These data suggest that formation of synapses correlates with the activation of a putative low-affinity calcium sensor, which allows synaptic vesicle exocytosis to be triggered and turned off over extremely short time scales, in response to large increases in the level of intracellular calcium.


Subject(s)
Calcium/physiology , Synapses/physiology , Synaptic Vesicles/physiology , Animals , Calcium/metabolism , Cells, Cultured , Cellular Senescence/physiology , Exocytosis/physiology , Extracellular Space/metabolism , Hippocampus/cytology , Hippocampus/physiology , Neurons/physiology , Osmolar Concentration , Rats , Synaptic Transmission/physiology , Time Factors
16.
Eur J Neurosci ; 7(10): 2083-92, 1995 Oct 01.
Article in English | MEDLINE | ID: mdl-8542065

ABSTRACT

IMR32 cells express two classes of surface nicotinic receptors: those labelled with high affinity by [125I]neuronal toxin, and those labelled by [125I]alpha-bungarotoxin. Whole-cell patch-clamp recordings indicate that both classes of receptor are able to elicit inward currents that are totally blocked by d-tubocurarine but only partially blocked by alpha-bungarotoxin. In IMR32 cells, nicotine induces an increase in the intracellular level of free Ca2+. This increase, which is also completely blocked by d-tubocurarine and only partially blocked by alpha-bungarotoxin and Cd2+, is due to extracellular calcium influx through both the nicotinic receptors and the voltage-activated Ca2+ channels. By using subunit-specific polyclonal antibodies, we have demonstrated that the alpha-bungarotoxin receptors contain the alpha 7 subunit, but none of the other subunits whose transcripts are present in IMR32 cells. The pharmacological profile of these human alpha 7-containing alpha-bungarotoxin receptors is similar to that observed in the native chick alpha 7 receptor, but there are also some species-specific differences.


Subject(s)
Neuroblastoma , Receptors, Nicotinic/drug effects , Receptors, Nicotinic/immunology , Receptors, Nicotinic/physiology , Antibodies/immunology , Binding, Competitive , Bungarotoxins/pharmacology , Calcium/metabolism , Cells, Cultured , Electrophoresis , Fura-2 , Humans , Patch-Clamp Techniques , Radioligand Assay
18.
J Neurosci ; 15(6): 4328-42, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7540672

ABSTRACT

Antibodies directed against the lumenal domain of synaptotagmin I conjugated to CY3 (CY3-Syt1-Abs) and video microscopy were used to study the dynamics of synaptic vesicles in cultured hippocampal neurons. When applied to cultures after synapse formation, CY3-Syt1-Abs produced a strong labeling of presynaptic vesicle clusters which was markedly increased by membrane depolarization. The increase of the rate of CY3-Syt1-Ab uptake in a high K+ medium was maximal during the first few minutes but persisted for as long as 60 min. In axons developing in isolation, CY3-Syt1-Abs, in combination with electron microscopy immunocytochemistry, revealed the presence of synaptic vesicle clusters which move in bulk in anterograde and retrograde direction. Clusters are present both in the axon shaft and in filopodia but not in the filopodia of the growth cone. Both presynaptic vesicle clusters and clusters present in isolated axons were disrupted by okadaic acid as previously shown for synaptic vesicle clusters at the frog neuromuscular junction. These findings indicate that synaptic vesicle aggregation may occur independently of cell-cell interaction, but that, in the absence of a synaptic contact, vesicle clusters are not stably anchored to a given region of the cell surface. Labeling of synaptic vesicles in immature isolated neurons was found to be depolarization and Ca2+ dependent, demonstrating that Ca(2+)-regulated exocytosis is an intrinsic characteristic of synaptic vesicles irrespective of their localization at a synapse.


Subject(s)
Antibodies/pharmacology , Axons/physiology , Calcium-Binding Proteins , Hippocampus/physiology , Membrane Glycoproteins/physiology , Nerve Tissue Proteins/physiology , Neurons/physiology , Synaptic Vesicles/physiology , Animals , Antibodies, Monoclonal/pharmacology , Axons/drug effects , Axons/ultrastructure , Cells, Cultured , Epitopes/immunology , Ethers, Cyclic/pharmacology , Fetus , Hippocampus/cytology , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/immunology , Mice/immunology , Microscopy, Electron , Nerve Tissue Proteins/antagonists & inhibitors , Nerve Tissue Proteins/immunology , Neurons/drug effects , Neurons/ultrastructure , Okadaic Acid , Potassium/pharmacology , Rabbits/immunology , Rats , Synaptic Vesicles/drug effects , Synaptic Vesicles/ultrastructure , Synaptotagmin I , Synaptotagmins
19.
Proc Natl Acad Sci U S A ; 93(23): 13310-5, 1996 Nov 12.
Article in English | MEDLINE | ID: mdl-8917587

ABSTRACT

Tetanus neurotoxin causes the spastic paralysis of tetanus by blocking neurotransmitter release at inhibitory synapses of the spinal cord. This is due to the penetration of the toxin inside the neuronal cytosol where it cleaves specifically VAMP/synaptobrevin, an essential component of the neuroexocytosis apparatus. Here we show that tetanus neurotoxin is internalized inside the lumen of small synaptic vesicles following the process of vesicle reuptake. Vesicle acidification is essential for the toxin translocation in the cytosol, which results in the proteolytic cleavage of VAMP/ synaptobrevin and block of exocytosis.


Subject(s)
Endocytosis , Hippocampus/physiology , Macrolides , Neurons/physiology , Neurotoxins/metabolism , Synaptic Vesicles/physiology , Tetanus Toxin/metabolism , Animals , Anti-Bacterial Agents/pharmacology , Cells, Cultured , Cytosol/metabolism , Enzyme Inhibitors/pharmacology , Fetus , Immunohistochemistry , Membrane Proteins/metabolism , Microscopy, Immunoelectron , Nerve Endings/physiology , Nerve Endings/ultrastructure , Neurons/cytology , R-SNARE Proteins , Rats , Synaptic Vesicles/drug effects , Synaptic Vesicles/ultrastructure , Transferrin/metabolism
20.
Eur J Neurosci ; 11(8): 2793-800, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10457176

ABSTRACT

Synchronous oscillations of intracellular calcium concentration ([Ca2+]i) and of membrane potential occurred in a limited population of glutamatergic hippocampal neurons grown in primary cultures. The oscillatory activity occurred in synaptically connected cells only when they were in the presence of astrocytes. Microcultures containing only one or a few neurons also displayed oscillatory activity, provided that glial cells participated in the network. The glutamate-transporter inhibitors L-trans-pyrrolidine-2, 4-dicarboxylic acid (PDC) and dihydrokainate, which produce an accumulation of glutamate in the synaptic microenvironment, impaired the oscillatory activity. Moreover, in neurons not spontaneously oscillating, though in the presence of astrocytes, oscillations were induced by exogenous L-glutamate, but not by the stereoisomer D-glutamate, which is not taken up by glutamate transporters. These data demonstrate that astrocytes are essential for neuronal oscillatory activity and provide evidence that removal of glutamate from the synaptic environment is one of the major mechanisms by which glial cells allow the repetitive excitation of the postsynaptic cell.


Subject(s)
Astrocytes/physiology , Hippocampus/physiology , Neurons/physiology , ATP-Binding Cassette Transporters/antagonists & inhibitors , Amino Acid Transport System X-AG , Animals , Calcium/metabolism , Cells, Cultured , Dicarboxylic Acids/pharmacology , Glutamic Acid/metabolism , Hippocampus/cytology , Hippocampus/drug effects , Hippocampus/embryology , Intracellular Membranes/metabolism , Kainic Acid/analogs & derivatives , Kainic Acid/pharmacology , Membrane Potentials/physiology , Neurons/drug effects , Neurons/metabolism , Oscillometry , Osmolar Concentration , Pyrrolidines/pharmacology , Rats , Synapses/physiology
SELECTION OF CITATIONS
SEARCH DETAIL